Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout
Wellcome Collection
By Meghana Keshavan
May 14, 2026
Biotech Correspondent
Meghana Keshavan
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
A year after Vertex’s big launch, pain drug research faces a pivotal moment
Regulatory tracker: Taiho's Inqovi widens its reach with FDA label expansion
Integrated CDO capabilities reduce early development complexity
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
FDA floats possible approach to repurpose approved drugs under new uses
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news
Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout
A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates
Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
